P/E at 65.25 vs Industry's 65.95: What the Data Shows for Max Healthcare Institute Ltd

Valuation Picture: Premium or Parity?

The current P/E of Max Healthcare Institute Ltd stands at 65.25, marginally below the hospital industry average of 65.95. This near parity suggests the market values the company’s earnings similarly to its sector peers, reflecting neither a significant premium nor discount. Such valuation alignment often indicates that investors price in comparable growth prospects and risk profiles. However, given the stock’s mid-cap status with a market capitalisation of ₹96,519.83 crores, this valuation level is notable for a company outside the large-cap bracket. The question arises — what is the current rating for Max Healthcare Institute Ltd given this valuation context?

Performance Across Timeframes: Divergent Momentum

Examining returns over various periods reveals a nuanced performance trajectory. Over the past year, Max Healthcare Institute Ltd has declined by 18.13%, significantly underperforming the Sensex’s 4.68% fall. This underperformance is even more pronounced in shorter timeframes: the stock lost 6.32% over three months while the Sensex gained 2.86%. The one-month and one-week returns are also negative at -8.99% and -4.64% respectively, compared to the Sensex’s modest declines of less than 1%. Even the day’s performance shows a sharper fall of 1.21% versus the Sensex’s 0.34% drop.

Yet, the year-to-date return of -5.09% is less severe than the Sensex’s -9.10%, indicating some recovery or resilience in recent months. This mixed momentum — is this a temporary reprieve or a sign of stabilisation after a prolonged downtrend? — complicates the narrative for investors assessing the stock’s near-term prospects.

Moving Average Configuration: Bearish Territory

The technical picture for Max Healthcare Institute Ltd remains firmly bearish. The stock is trading below all key moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — signalling sustained downward pressure. This configuration typically reflects a persistent downtrend without signs of immediate recovery. The absence of any short-term bounce above the 5-day or 20-day averages suggests that recent price action has failed to gain upward momentum. The question investors face is whether this technical setup represents a continuation of weakness or a base for a future turnaround — is this a genuine recovery or a dead-cat bounce at the 50 DMA?

Relative Performance Versus Sensex: A Mixed Bag

Over longer horizons, Max Healthcare Institute Ltd has outperformed the Sensex substantially. The three-year return of 85.90% dwarfs the Sensex’s 19.28%, while the five-year gain of 189.13% far exceeds the Sensex’s 39.26%. This strong historical performance contrasts sharply with the recent underperformance, highlighting a shift in momentum. The absence of a 10-year return figure suggests the stock’s listing or corporate structure has changed within the last decade, limiting longer-term comparisons.

This divergence between strong medium-term gains and recent weakness raises the question — should investors in Max Healthcare hold, buy more, or reconsider?

Sector Performance Context

The hospital sector, to which Max Healthcare Institute Ltd belongs, has experienced mixed results recently. While some peers have managed to maintain or grow valuations, others have faced pressure from regulatory changes and cost inflation. The sector’s average P/E of 65.95 reflects a premium valuation typical of healthcare services with growth potential. Within this environment, Max Healthcare Institute Ltd’s valuation alignment with the sector average suggests it is neither an outlier nor a laggard in terms of market sentiment.

Rating Reassessment: From Sell to Hold

Previously rated Sell by MarketsMOJO, Max Healthcare Institute Ltd had its rating updated on 24 Jul 2026. The current Mojo Score stands at 50.0, reflecting a Hold stance. This shift indicates a reassessment of the company’s fundamentals and market position, likely influenced by the valuation parity and recent performance trends. The rating update invites investors to reanalyse the stock’s prospects in light of its current valuation and technical setup — what is the current rating for Max Healthcare Institute Ltd?

Consolidated View: What the Data Collectively Shows

The data on Max Healthcare Institute Ltd paints a picture of a mid-cap hospital stock trading at a valuation closely aligned with its sector peers. Despite a challenging recent performance marked by declines across short and medium-term periods, the stock’s longer-term returns remain robust. The technical indicators, however, signal caution with the stock below all major moving averages, suggesting the downtrend has not yet been broken.

Its rating reassessment from Sell to Hold reflects this complex scenario, balancing valuation parity and historical strength against recent momentum weakness. Investors face a nuanced decision — should they maintain their position, increase exposure, or look elsewhere?

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today